Serum levels of soluble interferon alfa/beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C

Hepatology

Volumn 30, Issue 5, 1999, Pages 1325-1331

  Mizukoshi, Eishiro ^a   Kaneko, Shuichi ^a   Kaji, Kyosuke ^a   Terasaki, Shuichi ^a   Matsushita, Eiki ^a   Muraguchi, Masahiro ^b   Ohmoto, Yasukazu ^b   Kobayashi, Kenichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON RECEPTOR; BETA INTERFERON RECEPTOR; INTERFERON; INTERFERON RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; DRUG EFFICACY; ENZYME BLOOD LEVEL; FEMALE; HEPATITIS C; HUMAN; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; PRIORITY JOURNAL; RECEPTOR DENSITY;

2',5'-OLIGOADENYLATE SYNTHETASE; ADULT; AGED; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; LIVER; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; REFERENCE VALUES; REGRESSION ANALYSIS; RNA, VIRAL; TREATMENT OUTCOME;

EID: 0032754656     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510300516     Document Type: Article

References (12)

1. Aguet M, Mogensen KE. Interferon receptors. In: Gresser I, ed. Interferon 5. New York: Academic Press, 1983;1-222.
2. Zoon KC, Arnheiter H. Studies of the interferon receptors. Pharmacol Ther 1984;24:259-278.
3. Fukuda R, Ishimura N, Kushiyama Y, Moriyama N, Ishihara S, Nagasawa S, Miyake T, et al. Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver. J Hepatol 1997;26:455-461.
4. Mizukoshi E, Kaneko S, Yanagi M, Ohno H, Kaji K, Terasaki S, Shimoda A, et al. Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients. J Med Virol 1998;56:217-223.
5. Morita K, Tanaka K, Saito S, Kitamura T, Kondo M, Sakaguchi T, Morimoto M, et al. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection. J Clin Gastroenterol 1998;26:135-140.
6. Yatsuhashi H, Yamasaki K, Aritomi T, Maria P, Carmen D, Inoue O, Koga M, et al. Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon. J Gastroenterol Hepatol 1997;12:460-7.
7. Domanski P, Witte M, Kellum M, Rubinstein M, Hackett R, Pitha P, Colamonici OR. Cloning and expression of a long form of the beta subunit of the interferon alpha beta receptor that is required for signaling. J Biol Chem 1995;270:21606-21611.
8. Lutfalla G, Holland SJ, Cinato E, Monneron D, Reboul J, Rogers NC, Smith JM, et al. Mutant U5A cells are complemented by an interferonalpha beta receptor subunit generated by alternative processing of a new member of a cytokine receptor gene cluster. Embo J 1995;14:5100-5108.
9. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell 1994;77:391-400.
10. Uze G, Lutfalla G, Gresser I. Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell 1990;60:225-234.
11. Novick D, Cohen B, Rubinstein M. Soluble interferon-alpha receptor molecules are present in body fluids. FEBS Lett 1992;314:445-448.
12. Novick D, Cohen B, Tal N, Rubinstein M. Soluble and membrane-anchored forms of the human IFN-alpha/beta receptor. J Leukoc Biol 1995;57:712-718.